Evidence map›Paper›PMID 33497410›Full record

Trial reportPloS one2021

Streptococcus pneumoniae carriage and antibiotic susceptibility among Indonesian pilgrims during the Hajj pilgrimage in 2015.

Kuntjoro Harimurti, Siti Rizny Fitriana Saldi, Esthika Dewiasty, Thafsin Alfarizi, Melzan Dharmayuli, Miftahuddin Majid Khoeri, Wisiva Tofriska Paramaiswari, Korrie Salsabila, Wisnu Tafroji, Carolina Halim and 3 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Whole genome sequencing data ofData in brief · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Transmission of Antimicrobial Resistant Bacteria at the Hajj: A Scoping Review.International journal of environmental research and public health · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Kuntjoro HarimurtiClinical Epidemiology and Evidence-Based Medicine (CEEBM) Unit, Cipto Mangunkusumo Hospital/Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
Siti Rizny Fitriana SaldiClinical Epidemiology and Evidence-Based Medicine (CEEBM) Unit, Cipto Mangunkusumo Hospital/Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
Esthika DewiastyClinical Epidemiology and Evidence-Based Medicine (CEEBM) Unit, Cipto Mangunkusumo Hospital/Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
Thafsin AlfariziCenter of Hajj Health, Ministry of Health, Jakarta, Indonesia.
Melzan DharmayuliCenter of Hajj Health, Ministry of Health, Jakarta, Indonesia.
Miftahuddin Majid KhoeriEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Wisiva Tofriska ParamaiswariEijkman Institute for Molecular Biology, Jakarta, Indonesia.ORCID 0000-0003-2808-5248
Korrie SalsabilaEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Wisnu TafrojiEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Carolina HalimPfizer Indonesia, Jakarta, Indonesia.
Qin JiangPfizer Inc., Collegeville, Pennsylvania, United States of America.
Amgad GamilPfizer Inc., Emerging Markets Medical & Scientific Affairs, Dubai, UAE.
Dodi SafariEijkman Institute for Molecular Biology, Jakarta, Indonesia.ORCID 0000-0002-7639-7441
Eijkman Institute for Molecular Biology · IDUniversity of Indonesia · IDMinistry of Health · IDPfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Hajj is an annual pilgrimage to Mecca and one of the largest gathering of people in the world. Most Indonesian pilgrims are senior adults and elderly adults, who are more prone to acquire infections during the Hajj ritual. The aims of this study are to investigate the dynamics of Streptococcus pneumoniae colonization and to investigate antibiotic susceptibility of pneumococcal strains in Indonesian pilgrims. This was a prospective multi-site longitudinal study in Indonesian hajj pilgrims aged >18 years old in the year 2015. Nasopharyngeal swabs were collected from the same subject before departure and upon arrival at the airport. S. pneumoniae was identified using conventional and molecular approach, while antibiotic susceptibility was determined using a disk diffusion method. Among 813 Hajj pilgrims who were enrolled from five sites in this study, the prevalence of S. pneumoniae carriage rates before- and after-the Hajj were 8.6% (95% CI 6.7-10.5%) and 8.2% (95% CI 6.4-10.1%), (p value: 0.844) respectively. Serotype 16F, 6A/6B, 3, 18, and 23F were the five most prevalent serotypes before Hajj, whereas serotypes 3, 34, 13, 4, and 23F were the most prevalent serotypes after Hajj. Serotype 3 was identified as most acquired serotype during Hajj in Indonesian pilgrim. There was an increase in the percentage of isolates susceptible to co-trimoxazole after Hajj (42.9% versus 57.4%). The study provided an overview of the change of dynamics of S. pneumoniae serotype acquisition in Indonesian Hajj Pilgrims. Along with data of vaccination serotypes coverage and antimicrobial susceptibility, these findings may contribute to recommendation of vaccination and treatment policies in the future.

Indexed as

Carrier StateCrowdingDrug Resistance, BacterialPneumococcal InfectionsStreptococcus pneumoniaeAdolescentAdultAnti-Bacterial AgentsFemaleHumansIndonesiaLongitudinal StudiesMaleMicrobial Sensitivity TestsMiddle AgedNasopharynxAnti-Bacterial Agents

Identifiers

PMID33497410
PMCPMC7837496
OpenAlexW3121329870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.